2024 annual financial data
Maze Therapeutics 2024 Net margin
Direct answer
Net margin was 31.18%.
Operating income was 57,586,000 USD and net income was 52,231,000 USD.
Operating cash flow was 75,954,000 USD.
Get free Maze Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 167,500,000 USD
- Operating income
- 57,586,000 USD
- Net income
- 52,231,000 USD
- Operating cash flow
- 75,954,000 USD